Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19

The coronavirus disease 2019 (COVID-19) global pandemic continues and antiviral agents and vaccines are currently under investigation. Mesenchymal stem cell (MSC)-based therapy can be a suitable option for management of patients with COVID-19 at the urgent time of virus outbreak. Currently, MSCs are...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenghai, Zhao, Hua, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533900/
https://www.ncbi.nlm.nih.gov/pubmed/33061304
http://dx.doi.org/10.2147/DDDT.S269407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533900/
https://www.ncbi.nlm.nih.gov/pubmed/33061304
http://dx.doi.org/10.2147/DDDT.S269407

Ejemplares similares